back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-06-03 17:12 Tx date 2025-05-29 |
$EDSA
Edesa Biotech, Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+65,000 vol |
65,000 | |
| Filed 2025-06-03 17:10 Tx date 2025-05-01 |
$EDSA
Edesa Biotech, Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-01-11 Tx date 2018-01-08 |
$RX
BioSyent Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$24,921
+2,596 vol $9.60 each |
8,517 | |
| Filed 2017-08-17 Tx date 2017-08-14 |
$RX
BioSyent Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
|
5,921 | ||
| Filed 2017-05-19 Tx date 2017-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$129,743
+25,641 vol $5.06 each |
105,531 | |
| Filed 2017-05-19 Tx date 2017-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$129,743
+25,641 vol $5.06 each |
||
| Filed 2017-05-16 Tx date 2017-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,325 vol |
3,429 | |
| Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,325 vol |
||
| Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,325 vol |
||
| Filed 2017-05-16 Tx date 2017-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,325 vol |
4,244 | |
| Filed 2017-04-03 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,325 vol |
4,244 | |
| Filed 2017-04-03 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,325 vol |
3,429 | |
| Filed 2016-07-05 Tx date 2016-07-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-3,000
-2,500 vol $1.20 each |
83,640 | |
| Filed 2016-07-05 Tx date 2016-07-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$3,000
+2,500 vol $1.20 each |
5,419 | |
| Filed 2016-07-05 Tx date 2016-07-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-2,500 vol |
2,919 | |
| Filed 2016-07-05 Tx date 2016-07-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$10,800
+3,750 vol $2.88 each |
6,669 | |
| Filed 2016-07-05 Tx date 2016-07-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-3,750 vol |
2,919 | |
| Filed 2016-07-05 Tx date 2016-07-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-10,800
-3,750 vol $2.88 each |
79,890 | |
| Filed 2016-03-27 Tx date 2016-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-181 vol |
2,919 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-391 vol |
4,754 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+391 vol |
3,100 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$73,943
+10,890 vol $6.79 each |
86,140 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+3,973 vol |
5,145 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+3,973 vol |
5,145 | |
| Filed 2015-12-17 Tx date 2015-12-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$162.40
+35 vol $4.64 each |
2,709 | |
| Filed 2015-12-17 Tx date 2015-12-14 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-3,200 vol |
2,674 | |
| Filed 2015-11-20 Tx date 2015-11-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,307
+449 vol $5.14 each |
5,874 | |
| Filed 2015-10-18 Tx date 2015-10-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,298
+486 vol $4.73 each |
5,425 |